September 2025 — U.S. Health Secretary Robert F. Kennedy Jr. is preparing to release a report suggesting that the use of acetaminophen, one of the most widely used over-the-counter pain medications, during pregnancy could be linked to a higher risk of autism in children. The report also highlights prenatal folate deficiency as a possible contributing factor and proposes folinic acid as a potential treatment option for some autism symptoms.
Contents of the Report
The document reportedly outlines three key claims:
- Prenatal acetaminophen exposure may be associated with an increased risk of autism.
- Low folate levels during pregnancy could further heighten developmental risks.
- Folinic acid therapy may provide some benefit for children already diagnosed with autism.
Kennedy argues that these findings challenge long-standing medical assumptions about the safety of acetaminophen in pregnancy.
Scientific Debate
Medical experts are divided. Some researchers acknowledge earlier studies that suggested correlations between acetaminophen use and developmental disorders, including autism and ADHD. However, many scientists stress that correlation does not equal causation. A number of large-scale studies have found no significant evidence that acetaminophen itself leads to autism.
Several health specialists also warn that confounding factors—such as underlying infections or conditions that led mothers to take the drug in the first place—may better explain the observed associations.
Industry and Professional Response
Pharmaceutical companies strongly reject the claims, reiterating that acetaminophen has been deemed safe for decades when used as directed. Medical associations are expected to issue statements urging caution, noting that prematurely discouraging its use could leave pregnant women without safe options for pain and fever relief.
Broader Implications
Kennedy has long been known for controversial stances on health issues, including vaccines. His new focus on pain medication and folate deficiency continues to spark debate over how public health policy should respond to inconclusive or conflicting evidence.
The release of this report could influence prescribing habits, consumer trust, and ongoing research into autism’s complex causes. Health experts emphasize the importance of rigorous scientific follow-up before drawing definitive conclusions.
Leave a Reply